Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registry.

SPECT myocardial perfusion imaging coronary artery disease early coronary revascularization explainable machine learning new-generation cardiac camera

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 31 10 2018
pubmed: 19 7 2019
medline: 29 6 2021
entrez: 19 7 2019
Statut: ppublish

Résumé

To optimize per-vessel prediction of early coronary revascularization (ECR) within 90 days after fast single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) using machine learning (ML) and introduce a method for a patient-specific explanation of ML results in a clinical setting. A total of 1980 patients with suspected coronary artery disease (CAD) underwent stress/rest 99mTc-sestamibi/tetrofosmin MPI with new-generation SPECT scanners were included. All patients had invasive coronary angiography within 6 months after SPECT MPI. ML utilized 18 clinical, 9 stress test, and 28 imaging variables to predict per-vessel and per-patient ECR with 10-fold cross-validation. Area under the receiver operator characteristics curve (AUC) of ML was compared with standard quantitative analysis [total perfusion deficit (TPD)] and expert interpretation. ECR was performed in 958 patients (48%). Per-vessel, the AUC of ECR prediction by ML (AUC 0.79, 95% confidence interval (CI) [0.77, 0.80]) was higher than by regional stress TPD (0.71, [0.70, 0.73]), combined-view stress TPD (AUC 0.71, 95% CI [0.69, 0.72]), or ischaemic TPD (AUC 0.72, 95% CI [0.71, 0.74]), all P < 0.001. Per-patient, the AUC of ECR prediction by ML (AUC 0.81, 95% CI [0.79, 0.83]) was higher than that of stress TPD, combined-view TPD, and ischaemic TPD, all P < 0.001. ML also outperformed nuclear cardiologists' expert interpretation of MPI for the prediction of early revascularization performance. A method to explain ML prediction for an individual patient was also developed. In patients with suspected CAD, the prediction of ECR by ML outperformed automatic MPI quantitation by TPDs (per-vessel and per-patient) or nuclear cardiologists' expert interpretation (per-patient).

Identifiants

pubmed: 31317178
pii: 5533091
doi: 10.1093/ehjci/jez177
pmc: PMC7167744
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-559

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL089765
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Références

Clin Nucl Med. 2012 Oct;37(10):965-70
pubmed: 22955070
J Nucl Cardiol. 2013 Aug;20(4):553-62
pubmed: 23703378
J Nucl Cardiol. 2016 Jun;23(3):606-39
pubmed: 26914678
J Nucl Cardiol. 2007 Apr;14(2):153-64
pubmed: 17386377
Ann Nucl Med. 2014 Feb;28(2):88-93
pubmed: 24343677
Circulation. 2003 Jun 17;107(23):2900-7
pubmed: 12771008
J Nucl Cardiol. 2018 Jun 19;:
pubmed: 29923104
JACC Cardiovasc Imaging. 2018 Nov;11(11):1654-1663
pubmed: 29550305
J Nucl Cardiol. 2014 Jun;21(3):478-85
pubmed: 24477404
J Nucl Cardiol. 2015 Oct;22(5):877-84
pubmed: 25480110
Nucl Med Commun. 2004 Jul;25(7):657-63
pubmed: 15208492
J Nucl Med. 2010 Nov;51(11):1724-31
pubmed: 20956478
Eur Heart J. 2017 Feb 14;38(7):500-507
pubmed: 27252451
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Eur Heart J. 2011 Apr;32(8):1012-24
pubmed: 21258084
J Nucl Cardiol. 2018 Feb;25(1):223-233
pubmed: 28303473
J Nucl Med. 2006 Jan;47(1):51-8
pubmed: 16391187
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1079-1090
pubmed: 29497801
J Am Coll Cardiol. 2012 Dec 18;60(24):e44-e164
pubmed: 23182125
N Engl J Med. 2007 Apr 12;356(15):1503-16
pubmed: 17387127
J Nucl Med. 2017 Jun;58(6):961-967
pubmed: 27811121
J Nucl Med. 2013 Apr;54(4):549-55
pubmed: 23482666
Bioinformatics. 2005 Aug 1;21(15):3301-7
pubmed: 15905277
J Am Coll Cardiol. 2012 Feb 28;59(9):857-81
pubmed: 22296741
Biom J. 2006 Aug;48(5):745-57
pubmed: 17094340

Auteurs

Lien-Hsin Hu (LH)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.
Department of Nuclear Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shipai Rd, Taipei, Taiwan.

Julian Betancur (J)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Tali Sharir (T)

Department of Nuclear Cardiology, Assuta Medical Center, HaBarzel St 20, Tel Aviv, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Rager Blvd, 84105 Be'er Sheva, Israel.

Andrew J Einstein (AJ)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, 622 W 168th St, New York, NY 10032, USA.
Department of Radiology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, 622 W 168th St, New York, NY 10032, USA.

Sabahat Bokhari (S)

Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, 622 W 168th St, New York, NY 10032, USA.
Department of Radiology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, 622 W 168th St, New York, NY 10032, USA.

Mathews B Fish (MB)

Department of Nuclear Medicine, Oregon Heart and Vascular Institute, Sacred Heart Medical Center, 3333 Riverbend Dr, Springfield, OR 97477, USA.

Terrence D Ruddy (TD)

Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.

Philipp A Kaufmann (PA)

Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland.

Albert J Sinusas (AJ)

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, 333 Cedar St, New Haven, CT 06510, USA.

Edward J Miller (EJ)

Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University, 333 Cedar St, New Haven, CT 06510, USA.

Timothy M Bateman (TM)

Cardiovascular Imaging Technologies LLC, 4320 Wormhall Rd, Kansas City, 64111 MO, USA.

Sharmila Dorbala (S)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

Marcelo Di Carli (M)

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

Guido Germano (G)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Frederic Commandeur (F)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Joanna X Liang (JX)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Yuka Otaki (Y)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Balaji K Tamarappoo (BK)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Damini Dey (D)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Daniel S Berman (DS)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Piotr J Slomka (PJ)

Department of Imaging, Medicine, and Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH